COMMENTARYProspective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation
References (20)
- et al.
The course of patients after variceal haemorrhage
Gastroenterology
(1981) - et al.
Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices
Lancet
(1993) - et al.
Endoscopic ligation of oesophageal varices compared with injection sclerotherapy: a prospective randomized trial
Gastrointest Endosc
(1993) - et al.
Octreotide infusion or emergency sclerotherapy for variceal haemorrhage
Lancet
(1993) - et al.
Initial results of a randomized, prospective study of combination banding and sclerotherapy vs sclerotherapy alone for haemostasis of bleeding oesophagogastric varices
Gastrointest Endosc
(1995) - et al.
Randomized comparison of ligation vs ligation plus sclerotherapy for oesophageal variceal bleeding
Gastromtest Endosc
(1995) - et al.
Effect of somatostatin on splanchnic haemodynamics in patients with cirrhosis of the liver and in normal subjects
Gastroenterology
(1981) - et al.
A prospective randomized controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices
J Hepatol
(1992) - et al.
Cirrhotics with variceal haemorrhage: the importance of the time interval between admission and the start of analysis for survival and rebleeding rates
Hepatology
(1989)
Cited by (197)
Management of liver failure in general intensive care unit
2020, Anaesthesia Critical Care and Pain MedicineCitation Excerpt :However, the delta SOFA score (difference between baseline and at 48 h or 3-day) seems to display various prognostic values when compared to the score value at 48 h or 3-day with respect to short-term mortality [69,90,217]. Persistence of 3 or 4 non-haematological organ failures at 3-day [69] or between 3-day and 7-day [29–220] predicted inhospital mortality with a specificity of 93% or 100%. The same results were observed regarding the use of organ replacement methods (vasopressors, mechanical ventilation, renal replacement therapeutic or artificial liver support systems) during the stay of patients in intensive care [77,115].
Endoscopic management of acute esophageal variceal bleeding
2017, Techniques in Gastrointestinal EndoscopyAddition of Somatostatin After Successful Endoscopic Variceal Ligation Does not Prevent Early Rebleeding in Comparison to Placebo: A Double Blind Randomized Controlled Trial
2015, Journal of Clinical and Experimental HepatologyCitation Excerpt :No other vasoactive agent, like somatostatin or octreotide, has been shown to reduce mortality in single studies or meta-analyses. Contrary to our results, Sung et al found better results when they studied combination of octreotide with EVL vs. EVL alone in AVB.33 They found better results with co-administration of octreotide in terms of need for transfusions, balloon tamponade and the rate of rebleeding.
Review article: Upper gastrointestinal bleeding – review of current evidence and implications for management
2024, Alimentary Pharmacology and TherapeuticsOne in four patients with gastrointestinal bleeding develops shock or hemodynamic instability: A systematic review and meta-analysis
2023, World Journal of Gastroenterology